黄嘌呤氧化还原酶缺失促进肝癌干细胞扩增
该研究探讨黄嘌呤氧化还原酶(XOR)在肝癌干细胞(CSC)自我更新中的作用。研究发现XOR在肝癌样本和肝CSC中低表达,XOR通过结合USP15促进KEAP1去泛素化稳定,进而泛素化降解Nrf2并增加活性氧积累,抑制肝CSC扩增和肿瘤形成。XOR可能成为靶向肝CSC的肝癌治疗靶点。
要点
- XOR在肝癌组织和肝CSC中低表达,其缺失促进CSC扩增和化疗耐药。
- XOR通过USP15-KEAP1-Nrf2轴增加活性氧,抑制肝CSC。
- XOR是靶向肝癌干细胞的潜在治疗靶点。
核心结论
- XOR缺失通过USP15-KEAP1-Nrf2通路促进肝CSC扩增,XOR是潜在肝癌治疗靶点。
研究设计与样本
- 研究在人肝癌样本和肝CSC中检测XOR表达,并通过机制实验分析XOR与USP15、KEAP1、Nrf2的相互作用。
主要发现
- XOR在人肝癌样本和肝CSC中低表达。
- XOR抑制肝CSC扩增、肿瘤形成和化疗耐药。
- XOR与USP15结合,促进KEAP1去泛素化稳定,导致Nrf2泛素化降解和活性氧积累。
临床怎么用
- XOR可能作为靶向肝CSC的肝癌治疗靶点,但需进一步临床验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Liver cancer stem cells (CSCs) exist in the tumor environment and are critically involved in the initiation and progression of hepatocellular carcinoma (HCC). However, the underlying molecular mechanisms of self-renewal and maintenance of liver CSCs remain poorly understood. APPROACH AND RESULTS: We identified that xanthine oxidoreductase (XOR), which was expressed at low levels in human HCC samples and liver CSCs, restrained HCC formation and chemoresistance by attenuating liver CSC propagation. Mechanistically, XOR physically interacts with ubiquitin-specific peptidase 15 (USP15), thereby promoting deubiquitination of Kelch-like ECH associated protein 1 (KEAP1) to stabilize its expression, which leads to degradation of Nrf2 (nuclear factor erythroid 2-related factor 2) through ubiquitination and subsequently reactive oxygen species accumulation in liver CSCs. Finally, our data reveal that XOR promotes USP15-mediated Nrf2-KEAP1 signaling to block liver CSCs and tumor propagation. CONCLUSION: We identified that XOR may represent a potential therapeutic target for clinical intervention in HCC driven by liver CSCs.
引用
- Sun Q, Zhang Z, Lu Y, et al. Loss of Xanthine Oxidoreductase Potentiates Propagation of Hepatocellular Carcinoma Stem Cells. Hepatology. 2020. PMID: 31578733. doi:10.1002/hep.30978
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。